Individuals Discontinuing Slimming Jabs Put On Weight Four Times Faster Than Those on Conventional Diets

A recent study reveals that people who come off new GLP-1 drugs like Mounjaro or Wegovy may regain reduced body mass far faster than those who end conventional lifestyle plans.

Research printed in a leading health publication demonstrates that while obese people frequently drop a large proportion of their body weight while on the medication, the weight returns at an estimated rate of nearly a kilo each month after stopping.

"People buying these medications need to be informed of the potential of fast rebound weight gain when the therapy concludes," cautioned expert Dr. Susan Jebb.

Such speed of regain implies a return to starting weight in about a year and a half.

Weighing Therapies

The research, which looked at 37 of trials involving over 9,000 of participants, compared the outcomes of the injectable medications with older methods.

The team point out that individuals who lose weight through lifestyle changes alone usually have a slower creep back—perhaps 100 grams monthly—after stopping.

Explaining the Fast Regain

Nutrition scientists believe the way of the jabs accounts for the amplified regain.

GLP-1 drugs copy a natural hormone called GLP-1, which controls hunger.

"Artificially providing the hormone levels several times higher than normal could lead to the body to generate a reduced amount of its own natural hormone, and could reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this medication results in hunger is uncontrolled, making excessive eating far more likely."

A Lifelong Condition?

The NHS recommend the injections for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.

A number of clinicians say that, considering the likelihood of weight regain, the therapy might need to be life-long.

This view is reinforced by drug manufacturers, who note that the results "underscore the persistent nature of obesity," comparing it to managing diseases like diabetes.

User Accounts

Individuals who have discontinued the medication report a intense resurgence of hunger.

"I experienced something activating and you're instantly extremely hungry," said one woman.

This difficulty is compounded if individuals have not developed sustainable lifestyle or habit modifications during treatment.

Widespread Adoption

Figures suggest that millions of adults in the UK have used weight-loss jabs in the last 12 months, with demand remaining high.

• Use is greater among women than men.
• The middle-aged age group shows the highest usage rates.
• Many access the medications through private prescriptions rather than public health services.

In conclusion, clinicians emphasize that while the jabs are powerful tools for weight loss, they are not a permanent solution and lasting health benefits likely depends on ongoing lifestyle support.